cDNA array analysis of cytobrush-collected normal and malignant cervical epithelial cells: a feasibility study.

[1]  T. Maruo,et al.  Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium , 2010, Cancer.

[2]  Tak-Hong Cheung,et al.  Expression genomics of cervical cancer: molecular classification and prediction of radiotherapy response by DNA microarray. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  David Yang,et al.  Identification of cervical cancer markers by cDNA and tissue microarrays. , 2003, Cancer research.

[4]  A. Ayhan,et al.  Overexpression of the c-Met/HGF receptor and its prognostic significance in uterine cervix carcinomas. , 2003, Gynecologic oncology.

[5]  S. Månér,et al.  Genetic alterations in cervical carcinomas: Frequent low‐level amplifications of oncogenes are associated with human papillomavirus infection , 2002, International journal of cancer.

[6]  H. Fujii,et al.  c-Met Expression in Gastric Cancer with Liver Metastasis , 2002, Oncology.

[7]  I. Jacobs,et al.  A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer , 2002, British Journal of Cancer.

[8]  K. Hui,et al.  Identification and characterization of genes involved in the carcinogenesis of human squamous cell cervical carcinoma , 2002, International journal of cancer.

[9]  S. Chew,et al.  Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix , 2002, British Journal of Cancer.

[10]  T. Aso,et al.  Hepatocyte growth factor/scatter factor is implicated in the mode of stromal invasion of uterine squamous cervical cancer. , 2001, Gynecologic oncology.

[11]  A. Haman,et al.  Implication of tyrosine kinase receptor and steel factor in cell density-dependent growth in cervical cancers and leukemias. , 2001, Cancer research.

[12]  C. Hsu,et al.  Prognostic value of nm23 expression in stage IB1 cervical carcinoma. , 2001, Japanese journal of clinical oncology.

[13]  M. von Knebel Doeberitz,et al.  Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri , 2001, International journal of cancer.

[14]  X. Sastre-Garau,et al.  Distinct patterns of alteration of myc genes associated with integration of human papillomavirus type 16 or type 45 DNA in two genital tumours. , 2000, The Journal of general virology.

[15]  P. Leung,et al.  Hepatocyte growth factor promotes in vitro scattering and morphogenesis of human cervical carcinoma cells. , 2000, Gynecologic oncology.

[16]  P. Comoglio,et al.  Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas , 2000, Oncogene.

[17]  A. Cheung,et al.  Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia. , 1999, European journal of cancer.

[18]  M. J. van de Vijver,et al.  Oncogene alterations in carcinomas of the uterine cervix: overexpression of the epidermal growth factor receptor is associated with poor prognosis. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  Wei Zhang,et al.  Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  C. S. Lee,et al.  nm23‐H1 protein immunoreactivity in intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix , 1998, Pathology international.

[21]  M. Nair,et al.  Ras and C-Myc Oncoproteins during Tumor Progression in the Uterine Cervix , 1998, Tumori.

[22]  J. O’Leary,et al.  Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix. , 1998, Journal of clinical pathology.

[23]  J E Darnell,et al.  Epidermal growth factor-induced growth inhibition requires Stat1 activation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  E. Auvinen,et al.  The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. , 1998, Experimental cell research.

[25]  A. N. Corps,et al.  Hepatocyte growth factor stimulates motility, chemotaxis and mitogenesis in ovarian carcinoma cells expressing high levels of c‐MET , 1997, International journal of cancer.

[26]  R. Kramer,et al.  Expression of the C‐Met/HGF receptor in human breast carcinoma: Correlation with tumor progression , 1997, International journal of cancer.

[27]  Harald zur Hausen,et al.  Papillomavirus infections — a major cause of human cancers , 1996 .

[28]  M. Marone,et al.  Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. , 1996, British Journal of Cancer.

[29]  A. Vaheri,et al.  Keratinocyte growth factor enhances urokinase-type plasminogen activator activity in HPV16 DNA-immortalized human uterine exocervical epithelial cells. , 1996, European journal of cell biology.

[30]  T. Wright,et al.  Molecular biology of cervical cancer and its precursors , 1995, Cancer.

[31]  M. Fukumoto,et al.  Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix. , 1995, Cancer.

[32]  A. Vaheri,et al.  Keratinocyte growth factor is a bifunctional regulator of HPV16 DNA- immortalized cervical epithelial cells , 1995, The Journal of cell biology.

[33]  P. Lambert,et al.  Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. von Knebel Doeberitz,et al.  Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions , 1994, Journal of virology.

[35]  R. Chaganti,et al.  ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix. , 1994, Cancer research.

[36]  S. Pinion,et al.  Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix , 1991, The Lancet.

[37]  Arnold J. Levine,et al.  The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 , 1990, Cell.

[38]  G. Temple,et al.  Oncogenic association of specific human papillomavirus types with cervical neoplasia. , 1987, Journal of the National Cancer Institute.

[39]  S. Ozalp,et al.  Bcl-2 expression in preinvasive and invasive cervical lesions. , 2002, European journal of gynaecological oncology.

[40]  D. Spandidos,et al.  K-ras mutations and HPV infection in cervicitis and intraepithelial neoplasias of the cervix. , 2002, Oncology reports.

[41]  P. Ravazoula,et al.  Immunohistochemical analysis of nm23-H1 expression in human cervical lesions. , 2000, European Journal of Gynaecological Oncology.

[42]  S. Kounelis,et al.  Expression of bcl-2 and bax in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix. , 2000, European journal of gynaecological oncology.

[43]  S. Hirohashi,et al.  Prognostic significance of the overexpression of c‐erbB‐2 protein in adenocarcinoma of the uterine cervix , 1994, Cancer.